Cosmos Health Inc. ($COSM) reported second-quarter 2026 revenue of $19.0 million, up 28.8% from a year earlier, while gross profit rose 29.9% to $1.5 million.
The company remained unprofitable, with operating loss narrowing to $2.9 million and net loss attributable to common shareholders widening to $6.1 million. Diluted earnings per share came in at -$0.10.
Cash used in operating activities was $1.7 million, and capital spending totaled $63,637. Cash and cash equivalents increased to $2.4 million, while total liabilities stood at $40.8 million.
- Revenue increased 28.8% year over year to $19.0 million.
- Gross profit improved to $1.5 million.
- Net loss widened to $6.1 million.
- Cash on hand rose to $2.4 million.
Shares fell 3.21% after the market close following the release.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
Cosmos Health Inc. Insider Trading Activity
Cosmos Health Inc. insiders have traded $COSM stock on the open market 5 times in the past 6 months. Of those trades, 5 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $COSM stock by insiders over the last 6 months:
- GRIGORIOS SIOKAS (Chief Executive Officer) has made 4 purchases buying 2,036,003 shares for an estimated $415,000 and 0 sales.
- GEORGIOS TERZIS (Chief Financial Officer) purchased 168,135 shares for an estimated $42,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Cosmos Health Inc. Hedge Fund Activity
We have seen 10 institutional investors add shares of Cosmos Health Inc. stock to their portfolio, and 13 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG added 581,728 shares (+4568.3%) to their portfolio in Q2 2026, for an estimated $107,445
- RENAISSANCE TECHNOLOGIES LLC removed 390,500 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $72,125
- JANE STREET GROUP, LLC added 289,287 shares (+inf%) to their portfolio in Q2 2026, for an estimated $53,431
- HRT FINANCIAL LP removed 67,280 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $12,426
- XTX TOPCO LTD removed 40,477 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $7,476
- CITADEL ADVISORS LLC removed 40,306 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $7,444
- TWO SIGMA SECURITIES, LLC removed 36,290 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $11,511
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
